Cargando…
Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
The advent of first and second-generation immune checkpoint blockade (ICI) has resulted in improved survival of patients with metastatic melanoma over the past decade. However, the majority of patients ultimately progress despite these treatments, which has served as an impetus to consider a range o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958874/ https://www.ncbi.nlm.nih.gov/pubmed/33732652 http://dx.doi.org/10.3389/fonc.2021.640314 |